MedTrace Logo

Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement

NCT03180073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-02-21

No results posted yet for this study

Summary

Most of the conduction abnormalities with TAVR are usually detected during the procedure or during the following days of observation. Little is known about the prevalence and timing of any conduction abnormalities that exist before (other than standard ECG) or after through long term cardiac monitoring.

Conditions

  • Bradycardia

Interventions

DIAGNOSTIC_TEST

Ziopatch Pre discharge

Ziopatch applied 2 weeks prior to procedure

DIAGNOSTIC_TEST

Ziopatch at Discharge

Ziopatch applied at discharge from hospital to be worn for 2 weeks

DIAGNOSTIC_TEST

Ziopatch at 2 months

Ziopatch applied 2 months from procedure to be worn for 2 weeks

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Khaldoun Tarakji, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2020-12-23
Completion
2020-12-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03180073 on ClinicalTrials.gov